Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
MDGL

Updated 10/6/2026, 10:27 AM ET.

MDGL

MADRIGAL PHARMACEUTICALS, INC.

Sale$6,239,198

Sibold William John

President and CEO, Director

11,583 shat $538.65Filed Sep 11, 4:57 PM ET
Filing
MDGL

MADRIGAL PHARMACEUTICALS, INC.

Sale$341,940

Kelley Shannon T

General Counsel

664 shat $514.97Filed Aug 20, 4:20 PM ETFiling
MDGL

MADRIGAL PHARMACEUTICALS, INC.

Sale$1,368,253

Sibold William John

President and CEO, Director

2,500 shat $547.30Filed Jul 20, 9:16 PM ETFiling

Read from public SEC filings. Not financial advice.